12 completed, 5 recruiting, 3 unknown, 1 terminated. 22 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 22 | Completed 12, Recruiting 5, Unknown 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 4, Recruiting 2, Unknown 1 |
Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Oral THC and CBD in Men and Women Placebo, THC, CBD - Drug Abuse, Intoxication by Drug | Phase 1 | Recruiting | University of California, Los Angeles | 22 | 2026-08-13 | 2026-09-08 |
| The Pharmacokinetics of a Hemp-Based Topical Product CBD, THC - Cannabis | Phase 1 | Recruiting | Johns Hopkins University | 20 | 2026-05-26 | 2026-09-03 |
| Study of Cannabidiol and Neuroimaging on Stress Cannabidiol, Placebo - Early Life Adversity, Trauma | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 160 | 2025-10-29 | 2026-09-10 |
| Warrior CARE: Cannabis Behavioral Health Tetrahydrocannabinol, Cannabidiol, Placebo - Post Traumatic Stress Disorder, Cannabis Use | Phase 1 / Phase 2 | Recruiting | Wayne State University | 500 | 2025-09-22 | 2026-08-07 |
| Cannabidiol (CBD) in Adults With ASD Cannabidiol, Placebo - Autism Spectrum Disorder | Phase 1 | Recruiting | Johns Hopkins University | 40 | 2023-04-20 | 2026-11-06 |
| A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users cannabis 0 mg, placebo, Cannabis 20 mg,, Cannabis 50 mg - Cannabis | Phase 1 / Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 70 | 2022-07-22 | 2024-04-22 |
| CBD in Postmenopausal Women With Osteopenia CBD, Placebo - Osteopenia | Phase 1 | Terminated | Canopy Growth Corporation | 2 | 2022-05-01 | 2022-09-23 |
| Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task CBD, Placebo - CBD | Phase 1 / Phase 2 | Unknown | Hartford Hospital | 20 | 2021-12-15 | 2024-04-12 |
| Therapeutic Response of Cannabidiol in Rheumatoid Arthritis 200mg Cannabidiol by capsules twice daily, 400mg Cannabidiol by capsules twice daily, Placebo capsules - Rheumatoid Arthritis, Cannabis | Phase 1 | Completed | University of California, Los Angeles | 67 | 2021-10-05 | 2024-06-07 |
| The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management CBD - CBD, Pain, Chronic | Phase 1 | Unknown | Advanced Pain and Rehab Specialists | 30 | 2021-09-01 | 2021-08-06 |
| The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions CBD, THC - Cannabis, Drug Effects | Phase 1 | Completed | Johns Hopkins University | 75 | 2021-08-15 | 2024-08-07 |
| The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products CBD, THC, Placebo - Cannabis, Drug Effect | Phase 1 | Completed | Johns Hopkins University | 47 | 2021-07-14 | 2023-03-10 |
| Synthetic CBD as a Therapy for COVID-19 CBD, Placebo - Covid19, CBD | Phase 1 | Unknown | Sheba Medical Center | 50 | 2021-01-20 | 2021-09-28 |
| Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients. cannabidiol, floss, proxabrush - Periodontitis, Adult, Inflammation Gum | Phase 1 | Withdrawn | University of Nebraska | 2020-05-14 | 2024-09-03 | |
| Cannabidiol as a Treatment for AUD Comorbid With PTSD Cannabidiol, Placebos - Alcohol Use Disorder, Post Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | NYU Langone Health | 95 | 2019-09-16 | 2023-06-28 |
| Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam THC, Alprazolam, Placebo oral capsule - Cannabis Use Disorder | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 42 | 2017-12-04 | 2018-06-14 |
| Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers Cannabidiol, Placebo - Pain | Phase 1 / Phase 2 | Completed | University of California, Los Angeles | 18 | 2016-07-01 | 2021-05-12 |
| University of Alabama at Birmingham (UAB) Adult CBD Program Epidiolex - Epilepsy, Seizures | Phase 1 | Completed | University of Alabama at Birmingham | 80 | 2015-04-01 | 2020-05-08 |
| University of Alabama at Birmingham (UAB) Pediatric CBD Program Epidiolex - Epilepsy, Seizures | Phase 1 | Completed | University of Alabama at Birmingham | 89 | 2015-04-01 | 2020-04-10 |
| Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome Cannabidiol - Sturge-Weber Syndrome | Phase 1 / Phase 2 | Completed | Anne Comi, MD | 5 | 2014-12-01 | 2022-03-02 |
Showing 20 of 22. Sign in to see all of them.
Marijuana Abuse (6) · Anxiety Disorders (2) · Epilepsy (2) · Seizures (2) · Stress Disorders, Post-Traumatic (2) · Alcoholism (1) · Arthritis, Rheumatoid (1) · Autism Spectrum Disorder (1) · Bone Diseases, Metabolic (1) · COVID-19 (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Chronic Pain (1) · Chronic Periodontitis (1) · Drug Resistant Epilepsy (1)
Johns Hopkins University (4) · University of California, Los Angeles (3) · Calithera Biosciences, Inc (2) · University of Alabama at Birmingham (2) · Advanced Pain and Rehab Specialists (1) · Anne Comi, MD (1) · Canopy Growth Corporation (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Hartford Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · NYU Langone Health (1) · National Institute on Drug Abuse (NIDA) (1) · Sheba Medical Center (1) · University of Nebraska (1) · Wayne State University (1)
United States (19) · Canada (1) · Israel (1)
Tory Spindle, PhD (2) · Anne M Comi, MD (1) · Charles Marmar, MD (1) · Debra Kelsh, MD (1) · Didier Jutras-Aswad, MD,MS (1) · Elizabeth Wise, MD (1) · Godfrey Pearlson, MD (1) · Howard Amital, MD, MHA (1) · Jerzy Szaflarski, MD, PhD (1) · Joseph B Bavitz, DMD (1) · Keith W Orford, MD, PhD (1) · Keren Bachi, PhD (1) · Lance Rudolph, MD (1) · Martina Bebin, MD (1) · Ryan Vandrey, PhD (1)
PMID 29063814, PMID 31048098, PMID 39719161, PMID 41514385, PMID 42454450
R01MH139940 (1)